No Nazi merchandise from Druck18: Laut gegen Nazis e.V. secures trademark rights to Germany's largest online Nazi shop
18.8.2025 13:53:27 CEST | news aktuell GmbH | Press Release
● The initiative is part of the award-winning “Rights Against the Right“ campaign by Laut gegen Nazis e.V. and the advertising agency Jung von Matt

Hamburg, August 18, 2025. Together with Jung von Matt, the association has trademarked the name of Germany's largest right-wing extremist online shop, “Druck 18.”
Druck18 is considered Germany's largest Nazi merchandise shop, run by neo-Nazi Tommy Frenck, who is regarded as one of the central figures in the right-wing extremist scene. His online shop offers hundreds of items with racist, anti-Semitic, and historical revisionist content.
"We have already proven with the trademark registration of individual codes that we hit Nazis where it hurts them most: their wallets. With ‘Druck18’, we are going one step further,“ says Jörn Menge, founder of Laut gegen Nazis e.V. ”To keep the rights to druck18 and all our secured codes, we need to sell merch bearing them. That’s what we do now under: www.druck18.com“
As part of the Rights against the Right campaign, the association has trademarked the name of the online shop “Druck18” with the aim of preventing the commercial use of the name by the far-right scene. The operator is no longer allowed to continue running the shop under this name. Further use will result in legal consequences, including injunctions and claims for damages.
Philip Schlaffer, a former neo-Nazi, welcomes the move. He operated a right-wing extremist online shop and knows the scene from the inside: “Most of the scene is financed through merchandise, and Druck18 is the flagship. Anyone who interferes with that not only deprives the movement of money, but also of reach and ways of identification. This initiative really hits the mark.”
About Laut gegen Nazis
The association “Laut gegen Nazis” actively opposes the continuing growth of right-wing extremism. Since 2004, it has made it its mission to bring together civil society and generate strong public opposition to the ever-growing right-wing extremism. The NGO supports initiatives and alliances against the right wing in their public relations work, forms networks, and offers ongoing advice and support at local events. In this way, the association can contribute to shaping public opinion and strengthening civil society resistance—for fundamental democratic values and freedom
Contacts
info@druck18.com
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
WELEDA x Stella McCartney: Paris Fashion Week / Skin Food: 100 years of loving skin9.3.2026 13:30:04 CET | Press Release
Arlesheim, 09th March 2026. During this season’s Paris Fashion Week, WELEDA is backstage at the Stella McCartney show ensuring radiant skin: make-up artists draw specifically on the trusted nurturing power of the WELEDA Skin Food range to prep and prime the runway models’ skin perfectly for make-up and create a natural glow.
Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:40:44 CET | Press Release
Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain. Under the agreement, BCWP will be responsible for obtaining marketing authorisation for Qutenza® in South Korea. Upon approval, the company will market and distribute the product. Grünenthal will receive an upfront payment in addition to regulatory and sales-related milestone payments. “We are executing on a dedicated strategy to bring Qutenza® into the Asia-Pacific region to facilitate greater access to non-opioid treatment opt
Compax MVNE continues to support Airalo’s eSIM platform2.3.2026 13:38:56 CET | Press Release
Vienna, March 2nd, 2026: Compax, a leading solution provider in the MVNO and telco space, will continue to support Airalo, the world’s first and largest eSIM platform.
Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:07:51 CET | Press Release
Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.
Valle Venia presents new song by LPS feat. Lara: Where will it take me27.2.2026 10:15:00 CET | Press Release
The song describes the challenge of trusting the flow, relying on oneself, following one's own values with confidence. In a time when everything seems to begin to dissolve, when disorientation prevails more than ever and when one is searching for something to hold on to, certainty can be found in uncertainty. Lara's authentic interpretation, with her multi-faceted voice, conveys confidence in finding a way for oneself and others. In the faceless, noisy crowd, where glances are not returned and touches are not felt, one is pulled away by an invisible hand. You are on your own, but somewhere there is a light and a hope that guides you when the fog lifts and you find yourself in the certainty of meeting someone who “can read my mind and my soul.” Invisibly connected, across time and space, this path is open.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom